Added to YB: 2026-07-08
Pitch date: 2026-07-05
PSNL [bullish]
Personalis, Inc.
+2.64%
current return
Author Info
The Micro-Capo is a blog where I share news and articles on companies I like or own. Sign up for the newsletter.
Company Info
Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.
Market Cap
$1.4B
Pitch Price
$13.62
Price Target
N/A
Dividend
N/A
EV/EBITDA
-14.52
P/E
-13.32
EV/Sales
19.09
Sector
Life Sciences Tools and Services
Category
growth
The Micro-Capo | Monthly Report - New Position: Personalis, Inc.
PSNL (new position): Ultra-sensitive liquid biopsy (NeXT Personal) for minimal residual disease detection in cancer. Avg ~$9.29 (June 9/11 entries). June catalysts: ASCO data across 6 tumor types + CE-IVD marking in Europe. Up 45%, hit 12-mo high. Risk: CEO/CFO sold shares end of month.
Read full article (1 min)